Regeneron Pharmaceuticals, Inc. REGN reported mixed results for the first-quarter of 2018, wherein earnings topped expectations but sales missed the same.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,